S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:ETON

Eton Pharmaceuticals Stock Forecast, Price & News

$7.72
0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.03
Now: $7.72
$7.89
50-Day Range
$7.72
MA: $9.16
$10.07
52-Week Range
$2.50
Now: $7.72
$10.30
Volume225,511 shs
Average Volume165,368 shs
Market Capitalization$186.93 million
P/E RatioN/A
Dividend YieldN/A
Beta1.29
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.
Eton Pharmaceuticals logo

Headlines

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Profit Outlook
February 15, 2021 |  finance.yahoo.com
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
February 8, 2021 |  finance.yahoo.com
Eton Pharmaceuticals EPS misses by $0.06
November 12, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ETON
CUSIPN/A
CIKN/A
Phone847-787-7361
Employees17
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$460,000.00
Book Value$0.59 per share

Profitability

Net Income$-18,320,000.00

Miscellaneous

Market Cap$186.93 million
Next Earnings Date3/16/2021 (Confirmed)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.31 out of 5 stars

Medical Sector

761st out of 1,968 stocks

Pharmaceutical Preparations Industry

366th out of 771 stocks

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$7.72
0.00 (0.00 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ETON News and Ratings via Email

Sign-up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Eton Pharmaceuticals (NASDAQ:ETON) Frequently Asked Questions

Is Eton Pharmaceuticals a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eton Pharmaceuticals in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Eton Pharmaceuticals stock.
View analyst ratings for Eton Pharmaceuticals
or view top-rated stocks.

What stocks does MarketBeat like better than Eton Pharmaceuticals?

Wall Street analysts have given Eton Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eton Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Eton Pharmaceuticals' next earnings date?

Eton Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, March 16th 2021.
View our earnings forecast for Eton Pharmaceuticals
.

How can I listen to Eton Pharmaceuticals' earnings call?

Eton Pharmaceuticals will be holding an earnings conference call on Tuesday, March 16th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Eton Pharmaceuticals' earnings last quarter?

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) posted its quarterly earnings results on Thursday, November, 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.05. The company had revenue of ($0.16) million for the quarter, compared to analysts' expectations of $1.49 million.
View Eton Pharmaceuticals' earnings history
.

How has Eton Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?

Eton Pharmaceuticals' stock was trading at $4.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ETON shares have increased by 83.8% and is now trading at $7.72.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for ETON?

2 brokerages have issued 1-year price objectives for Eton Pharmaceuticals' shares. Their forecasts range from $10.00 to $15.00. On average, they anticipate Eton Pharmaceuticals' share price to reach $12.50 in the next twelve months. This suggests a possible upside of 61.9% from the stock's current price.
View analysts' price targets for Eton Pharmaceuticals
or view top-rated stocks among Wall Street analysts.

Who are Eton Pharmaceuticals' key executives?

Eton Pharmaceuticals' management team includes the following people:
  • Mr. Sean E. Brynjelsen, Pres, CEO & Director (Age 49, Pay $607.66k)
  • Mr. W. Wilson Troutman CPA, CFO, Treasurer & Sec. (Age 67, Pay $341.37k)
  • Mr. Paul Stickler, Sr. VP of Sales & Marketing
  • Ms. Bharathi Devarakonda, Sr. VP of Regulatory Affairs & Product Devel.
  • Ms. Ingrid Hoos, Sr. VP of Scientific Affairs
  • Mr. Scott Grossenbach, VP of Sales & Marketing
  • Mr. David Krempa CFA, VP of Bus. Devel.

Who are some of Eton Pharmaceuticals' key competitors?

What other stocks do shareholders of Eton Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eton Pharmaceuticals investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Amarin (AMRN), Myovant Sciences (MYOV), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), Vaxart (VXRT), CymaBay Therapeutics (CBAY), Fulcrum Therapeutics (FULC) and Moderna (MRNA).

When did Eton Pharmaceuticals IPO?

(ETON) raised $22 million in an IPO on Wednesday, November 14th 2018. The company issued 3,600,000 shares at a price of $6.00 per share. National Securities Corporation served as the underwriter for the IPO.

What is Eton Pharmaceuticals' stock symbol?

Eton Pharmaceuticals trades on the NASDAQ under the ticker symbol "ETON."

Who are Eton Pharmaceuticals' major shareholders?

Eton Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional investors include Opaleye Management Inc. (16.68%), BlackRock Inc. (4.35%), AWM Investment Company Inc. (4.01%), Northern Trust Corp (0.76%), Hood River Capital Management LLC (0.32%) and Diametric Capital LP (0.21%). Company insiders that own Eton Pharmaceuticals stock include Charles J Casamento, Opaleye Management Inc and Sean Brynjelsen.
View institutional ownership trends for Eton Pharmaceuticals
.

Which institutional investors are selling Eton Pharmaceuticals stock?

ETON stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., and Barclays PLC.
View insider buying and selling activity for Eton Pharmaceuticals
or view top insider-selling stocks.

Which institutional investors are buying Eton Pharmaceuticals stock?

ETON stock was acquired by a variety of institutional investors in the last quarter, including Opaleye Management Inc., AWM Investment Company Inc., Hood River Capital Management LLC, BlackRock Inc., JPMorgan Chase & Co., Diametric Capital LP, Northern Trust Corp, and Creative Planning. Company insiders that have bought Eton Pharmaceuticals stock in the last two years include Charles J Casamento, Opaleye Management Inc, and Sean Brynjelsen.
View insider buying and selling activity for Eton Pharmaceuticals
or or view top insider-buying stocks.

How do I buy shares of Eton Pharmaceuticals?

Shares of ETON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eton Pharmaceuticals' stock price today?

One share of ETON stock can currently be purchased for approximately $7.72.

How much money does Eton Pharmaceuticals make?

Eton Pharmaceuticals has a market capitalization of $186.93 million and generates $460,000.00 in revenue each year. The company earns $-18,320,000.00 in net income (profit) each year or ($1.03) on an earnings per share basis.

How many employees does Eton Pharmaceuticals have?

Eton Pharmaceuticals employs 17 workers across the globe.

What is Eton Pharmaceuticals' official website?

The official website for Eton Pharmaceuticals is www.etonpharma.com.

Where are Eton Pharmaceuticals' headquarters?

Eton Pharmaceuticals is headquartered at 21925 W. FIELD PARKWAY SUITE 235, DEER PARK IL, 60010.

How can I contact Eton Pharmaceuticals?

Eton Pharmaceuticals' mailing address is 21925 W. FIELD PARKWAY SUITE 235, DEER PARK IL, 60010. The company can be reached via phone at 847-787-7361 or via email at [email protected]


This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.